Cargando…
Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
Autores principales: | Faulkner, Lee, Wood, Sally, Van Eker, Diane, Alfirevic, Ana, Pirmohamed, Munir, Naisbitt, Dean, Park, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127670/ http://dx.doi.org/10.1186/2045-7022-4-S3-P112 |
Ejemplares similares
-
Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01
por: Ogese, Monday O, et al.
Publicado: (2021) -
Characterization
of Teicoplanin-Specific T-Cells
from Drug Naïve Donors Expressing HLA-A*32:01
por: Gardner, Joshua, et al.
Publicado: (2022) -
HLA-DQ restricted activation of nitroso-sulfamethoxazole-specific CD4+ T-lymphocytes
por: Ogese, Monday, et al.
Publicado: (2014) -
Drug Induced Hypersensitivity and the HLA Complex
por: Alfirevic, Ana, et al.
Publicado: (2010) -
Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury
por: Saide, Katy, et al.
Publicado: (2014)